{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T09:34:13Z","timestamp":1774085653241,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,11,3]],"date-time":"2018-11-03T00:00:00Z","timestamp":1541203200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s11060-018-03003-z","type":"journal-article","created":{"date-parts":[[2018,11,3]],"date-time":"2018-11-03T09:13:38Z","timestamp":1541236418000},"page":"717-725","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Pre-irradiation intensive induction and marrow-ablative consolidation chemotherapy in young children with newly diagnosed high-grade brainstem gliomas: report of the \u201chead-start\u201d I and II clinical trials"],"prefix":"10.1007","volume":"140","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1082-7338","authenticated-orcid":false,"given":"Diana S.","family":"Osorio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neha","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyun","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Sposto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Stanek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon L.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey C.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Cornelius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey B.","family":"McCowage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Termuhlen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ira J.","family":"Dunkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Comito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Garvin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan L.","family":"Finlay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,3]]},"reference":[{"issue":"6","key":"3003_CR1","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1136\/adc.80.6.558","volume":"80","author":"DA Walker","year":"1999","unstructured":"Walker DA, Punt JA, Sokal M (1999) Clinical management of brain stem glioma. Arch Dis Child 80(6):558\u2013564","journal-title":"Arch Dis Child"},{"issue":"5","key":"3003_CR2","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s003810050379","volume":"15","author":"M Cartmill","year":"1999","unstructured":"Cartmill M, Punt J (1999) Diffuse brain stem glioma. A review of stereotactic biopsies. Childs Nerv Syst 15(5):235\u2013237","journal-title":"Childs Nerv Syst"},{"issue":"2","key":"3003_CR3","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1177\/088307389300800203","volume":"8","author":"BL Maria","year":"1993","unstructured":"Maria BL, Rehder K, Eskin TA et al (1993) Brainstem glioma: I. Pathology, clinical features, and therapy. J Child Neurol 8(2):112\u2013128","journal-title":"J Child Neurol"},{"issue":"10","key":"3003_CR4","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1002\/pbc.26118","volume":"63","author":"JC Espinoza","year":"2016","unstructured":"Espinoza JC, Haley K, Patel N et al (2016) Outcome of young children with high-grade glioma treated with irradiation-avoiding intensive chemotherapy regimens: Final report of the Head Start II and III trials. Pediatr Blood Cancer 63(10):1806\u20131813","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"3003_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1159\/000121096","volume":"25","author":"RA Zimmerman","year":"1996","unstructured":"Zimmerman RA (1996) Neuroimaging of primary brainstem gliomas: diagnosis and course. Pediatr Neurosurg 25(1):45\u201353","journal-title":"Pediatr Neurosurg"},{"issue":"3","key":"3003_CR6","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1470-2045(06)70615-5","volume":"7","author":"D Hargrave","year":"2006","unstructured":"Hargrave D, Bartels U, Bouffet E (2006) Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol 7(3):241\u2013248","journal-title":"Lancet Oncol"},{"issue":"1","key":"3003_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ctrv.2011.06.007","volume":"38","author":"MH Jansen","year":"2012","unstructured":"Jansen MH, van Vuurden DG, Vandertop WP, Kaspers GJ (2012) Diffuse intrinsic pontine gliomas: a systematic update on clinical trials and biology. Cancer Treat Rev 38(1):27\u201335","journal-title":"Cancer Treat Rev"},{"issue":"6","key":"3003_CR8","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/0360-3016(87)90098-8","volume":"13","author":"PJ Eifel","year":"1987","unstructured":"Eifel PJ, Cassady JR, Belli JA (1987) Radiation therapy of tumors of the brainstem and midbrain in children: experience of the Joint Center for Radiation Therapy and Children\u2019s Hospital Medical Center (1971\u20131981). Int J Radiat Oncol Biol Phys 13(6):847\u2013852","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"3003_CR9","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/0360-3016(86)90325-1","volume":"12","author":"CR Freeman","year":"1986","unstructured":"Freeman CR, Suissa S (1986) Brain stem tumors in children: results of a survey of 62 patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 12(10):1823\u20131828","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"3003_CR10","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1002\/1097-0142(19940915)74:6<1827::AID-CNCR2820740628>3.0.CO;2-Q","volume":"74","author":"RJ Packer","year":"1994","unstructured":"Packer RJ, Boyett JM, Zimmerman RA et al (1994) Outcome of children with brain stem gliomas after treatment with 7800 cGy of hyperfractionated radiotherapy. A Childrens Cancer Group Phase I\/II Trial. Cancer 74(6):1827\u20131834","journal-title":"Cancer"},{"issue":"10","key":"3003_CR11","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1002\/(SICI)1097-0142(19960515)77:10<2150::AID-CNCR28>3.0.CO;2-T","volume":"77","author":"RJ Packer","year":"1996","unstructured":"Packer RJ, Prados M, Phillips P et al (1996) Treatment of children with newly diagnosed brain stem gliomas with intravenous recombinant beta-interferon and hyperfractionated radiation therapy: a childrens cancer group phase I\/II study. Cancer 77(10):2150\u20132156","journal-title":"Cancer"},{"issue":"1","key":"3003_CR12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1023\/A:1006360222643","volume":"44","author":"RI Jakacki","year":"1999","unstructured":"Jakacki RI, Siffert J, Jamison C, Velasquez L, Allen JC (1999) Dose-intensive, time-compressed procarbazine, CCNU, vincristine (PCV) with peripheral blood stem cell support and concurrent radiation in patients with newly diagnosed high-grade gliomas. J Neurooncol 44(1):77\u201383","journal-title":"J Neurooncol"},{"issue":"6","key":"3003_CR13","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1200\/JCO.2000.18.6.1246","volume":"18","author":"A Broniscer","year":"2000","unstructured":"Broniscer A, Leite CC, Lanchote VL, Machado TM, Cristofani LM (2000) Radiation therapy and high-dose tamoxifen in the treatment of patients with diffuse brainstem gliomas: results of a Brazilian cooperative study. Brainstem Glioma Cooperative Group. J Clin Oncol 18(6):1246\u20131253","journal-title":"J Clin Oncol"},{"issue":"12","key":"3003_CR14","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1002\/cncr.21534","volume":"104","author":"V Bernier-Chastagner","year":"2005","unstructured":"Bernier-Chastagner V, Grill J, Doz F et al (2005) Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas: results of a French Society of Paediatric Oncology Phase II Study. Cancer 104(12):2792\u20132797","journal-title":"Cancer"},{"issue":"5","key":"3003_CR15","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/bjc.1998.555","volume":"78","author":"EJ Estlin","year":"1998","unstructured":"Estlin EJ, Lashford L, Ablett S et al (1998) Phase I study of temozolomide in paediatric patients with advanced cancer. United Kingdom Children\u2019s Cancer Study Group. Br J Cancer 78(5):652\u2013661","journal-title":"Br J Cancer"},{"issue":"1","key":"3003_CR16","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/cncr.20741","volume":"103","author":"A Broniscer","year":"2005","unstructured":"Broniscer A, Iacono L, Chintagumpala M et al (2005) Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children: results of a multiinstitutional study (SJHG-98). Cancer 103(1):133\u2013139","journal-title":"Cancer"},{"issue":"18","key":"3003_CR17","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1016\/j.ejca.2010.06.115","volume":"46","author":"JR Sharp","year":"2010","unstructured":"Sharp JR, Bouffet E, Stempak D et al (2010) A multi-centre Canadian pilot study of metronomic temozolomide combined with radiotherapy for newly diagnosed paediatric brainstem glioma. Eur J Cancer 46(18):3271\u20133279","journal-title":"Eur J Cancer"},{"issue":"4","key":"3003_CR18","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1093\/neuonc\/noq205","volume":"13","author":"KJ Cohen","year":"2011","unstructured":"Cohen KJ, Heideman RL, Zhou T et al (2011) Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children\u2019s Oncology Group. Neuro-oncology 13(4):410\u2013416","journal-title":"Neuro-oncology"},{"issue":"11","key":"3003_CR19","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1200\/JCO.1989.7.11.1748","volume":"7","author":"AH Calvert","year":"1989","unstructured":"Calvert AH, Newell DR, Gumbrell LA et al (1989) Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J Clin Oncol 7(11):1748\u20131756","journal-title":"J Clin Oncol"},{"issue":"1","key":"3003_CR20","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1200\/JCO.1998.16.1.210","volume":"16","author":"WP Mason","year":"1998","unstructured":"Mason WP, Grovas A, Halpern S et al (1998) Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors. J Clin Oncol 16(1):210\u2013221","journal-title":"J Clin Oncol"},{"issue":"11","key":"3003_CR21","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1002\/cncr.23078","volume":"110","author":"M Fouladi","year":"2007","unstructured":"Fouladi M, Nicholson HS, Zhou T et al (2007) A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma\/primitive neuroectodermal tumor, or brainstem glioma: a Children\u2019s Oncology Group study. Cancer 110(11):2535\u20132541","journal-title":"Cancer"},{"issue":"16","key":"3003_CR22","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1200\/JCO.2002.04.109","volume":"20","author":"MT Jennings","year":"2002","unstructured":"Jennings MT, Sposto R, Boyett JM et al (2002) Preradiation chemotherapy in primary high-risk brainstem tumors: phase II study CCG-9941 of the Children\u2019s Cancer Group. J Clin Oncol 20(16):3431\u20133437","journal-title":"J Clin Oncol"},{"key":"3003_CR23","doi-asserted-by":"crossref","unstructured":"Jenkin RDT, Boesel C, Boesel C, Fau - Ertel I, Ertel I, Fau - Evans A et al. (1987) Brain-stem tumors in childhood: a prospective randomized trial of irradiation with and without adjuvant CCNU, VCR, and prednisone. A report of the Childrens Cancer Study Group. 66(2):227-233","DOI":"10.3171\/jns.1987.66.2.0227"},{"issue":"2","key":"3003_CR24","first-page":"153-161","volume":"19","author":"C Jones","year":"2016","unstructured":"Jones C, Karajannis MA, Jones DT et al. (2016) Pediatric high-grade glioma: biologically and clinically in need of new thinking. Neuro-oncology. 19(2):153-161","journal-title":"Neuro-oncology"},{"issue":"24","key":"3003_CR25","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1056\/NEJM199306173282401","volume":"328","author":"PK Duffner","year":"1993","unstructured":"Duffner PK, Horowitz ME, Krischer JP et al (1993) Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 328(24):1725\u20131731","journal-title":"N Engl J Med"},{"issue":"6","key":"3003_CR26","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0959-8049(02)00029-1","volume":"38","author":"F Doz","year":"2002","unstructured":"Doz F, Neuenschwander S, Bouffet E et al (2002) Carboplatin before and during radiation therapy for the treatment of malignant brain stem tumours: a study by the Societe Francaise d\u2019Oncologie Pediatrique. Eur J Cancer 38(6):815\u2013819","journal-title":"Eur J Cancer"},{"issue":"4","key":"3003_CR27","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1002\/1097-0142(19930815)72:4<1404::AID-CNCR2820720441>3.0.CO;2-G","volume":"72","author":"CS Kretschmar","year":"1993","unstructured":"Kretschmar CS, Tarbell NJ, Barnes PD, Krischer JP, Burger PC, Kun L (1993) Pre-irradiation chemotherapy and hyperfractionated radiation therapy 66 Gy for children with brain stem tumors. A phase II study of the Pediatric Oncology Group, Protocol 8833. Cancer 72(4):1404\u20131413","journal-title":"Cancer"},{"issue":"4","key":"3003_CR28","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1215\/15228517-2008-029","volume":"10","author":"D Frappaz","year":"2008","unstructured":"Frappaz D, Schell M, Thiesse P et al (2008) Preradiation chemotherapy may improve survival in pediatric diffuse intrinsic brainstem gliomas: final results of BSG 98 prospective trial. Neuro-oncology 10(4):599\u2013607","journal-title":"Neuro-oncology"},{"issue":"8","key":"3003_CR29","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/s00381-016-3153-8","volume":"32","author":"Z Gokce-Samar","year":"2016","unstructured":"Gokce-Samar Z, Beuriat PA, Faure-Conter C et al (2016) Pre-radiation chemotherapy improves survival in pediatric diffuse intrinsic pontine gliomas. Childs Nerv Syst 32(8):1415\u20131423","journal-title":"Childs Nerv Syst"},{"issue":"4","key":"3003_CR30","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/BF00686291","volume":"30","author":"MG Donelli","year":"1992","unstructured":"Donelli MG, Zucchetti M, D\u2019Incalci M (1992) Do anticancer agents reach the tumor target in the human brain? Cancer Chemother Pharmacol 30(4):251\u2013260","journal-title":"Cancer Chemother Pharmacol"},{"issue":"3","key":"3003_CR31","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1200\/JCO.1984.2.3.215","volume":"2","author":"PE Postmus","year":"1984","unstructured":"Postmus PE, Holthuis JJ, Haaxma-Reiche H et al (1984) Penetration of VP 16\u2013213 into cerebrospinal fluid after high-dose intravenous administration. J Clin Oncol 2(3):215\u2013220","journal-title":"J Clin Oncol"},{"issue":"4","key":"3003_CR32","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3171\/jns.1981.54.4.0455","volume":"54","author":"FH Hochberg","year":"1981","unstructured":"Hochberg FH, Parker LM, Takvorian T, Canellos GP, Zervas NT (1981) High-dose BCNU with autologous bone marrow rescue for recurrent glioblastoma multiforme. J Neurosurg 54(4):455\u2013460","journal-title":"J Neurosurg"},{"issue":"6","key":"3003_CR33","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/bjc.1988.308","volume":"58","author":"EK Mbidde","year":"1988","unstructured":"Mbidde EK, Selby PJ, Perren TJ et al (1988) High dose BCNU chemotherapy with autologous bone marrow transplantation and full dose radiotherapy for grade IV astrocytoma. Br J Cancer 58(6):779\u2013782","journal-title":"Br J Cancer"},{"issue":"5","key":"3003_CR34","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1200\/JCO.1987.5.5.783","volume":"5","author":"DB Johnson","year":"1987","unstructured":"Johnson DB, Thompson JM, Corwin JA et al (1987) Prolongation of survival for high-grade malignant gliomas with adjuvant high-dose BCNU and autologous bone marrow transplantation. J Clin Oncol 5(5):783\u2013789","journal-title":"J Clin Oncol"},{"issue":"2","key":"3003_CR35","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/sj.bmt.1702475","volume":"26","author":"V Papadakis","year":"2000","unstructured":"Papadakis V, Dunkel IJ, Cramer LD et al (2000) High-dose carmustine, thiotepa and etoposide followed by autologous bone marrow rescue for the treatment of high risk central nervous system tumors. Bone Marrow Transplant 26(2):153\u2013160","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"3003_CR36","first-page":"1419","volume":"63","author":"MS Edwards","year":"1979","unstructured":"Edwards MS, Levin VA, Seager ML, Pischer TL, Wilson CB (1979) Phase II evaluation of thioTEPA for treatment of central nervous system tumors. Cancer Treat Rep 63(8):1419\u20131421","journal-title":"Cancer Treat Rep"},{"issue":"3","key":"3003_CR37","first-page":"736","volume":"49","author":"RL Heideman","year":"1989","unstructured":"Heideman RL, Cole DE, Balis F et al (1989) Phase I and pharmacokinetic evaluation of thiotepa in the cerebrospinal fluid and plasma of pediatric patients: evidence for dose-dependent plasma clearance of thiotepa. Cancer Res 49(3):736\u2013741","journal-title":"Cancer Res"},{"key":"3003_CR38","first-page":"1833","volume":"30","author":"RLCD Tartaglia","year":"1989","unstructured":"Tartaglia RLCD, Heideman R, Balis F (1989) Chemosensitivity of central nervous tumors to thiotepa and tepa. Proc Am Assoc Cancer Res 30:1833","journal-title":"Proc Am Assoc Cancer Res"},{"key":"3003_CR39","first-page":"90","volume":"9","author":"JAT Ascendo","year":"1989","unstructured":"Ascendo JAT, Feldman (1989) High dose thiotepa with autologous bone marrow transplantation and localized radiotherapy for patients with astrocytoma grade III-IV. Proc Am Assoc Cancer Res 9:90","journal-title":"Proc Am Assoc Cancer Res"},{"issue":"1","key":"3003_CR40","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/1097-0142(19930701)72:1<271::AID-CNCR2820720147>3.0.CO;2-K","volume":"72","author":"RL Heideman","year":"1993","unstructured":"Heideman RL, Packer RJ, Reaman GH et al (1993) A phase II evaluation of thiotepa in pediatric central nervous system malignancies. Cancer 72(1):271\u2013275","journal-title":"Cancer"},{"issue":"8","key":"3003_CR41","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1200\/JCO.1993.11.8.1458","volume":"11","author":"RL Heideman","year":"1993","unstructured":"Heideman RL, Douglass EC, Krance RA et al (1993) High-dose chemotherapy and autologous bone marrow rescue followed by interstitial and external-beam radiotherapy in newly diagnosed pediatric malignant gliomas. J Clin Oncol 11(8):1458\u20131465","journal-title":"J Clin Oncol"},{"issue":"4","key":"3003_CR42","first-page":"227","volume":"9","author":"C Kalifa","year":"1992","unstructured":"Kalifa C, Hartmann O, Demeocq F et al (1992) High-dose busulfan and thiotepa with autologous bone marrow transplantation in childhood malignant brain tumors: a phase II study. Bone Marrow Transplant 9(4):227\u2013233","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"3003_CR43","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1200\/JCO.1996.14.9.2495","volume":"14","author":"JL Finlay","year":"1996","unstructured":"Finlay JL, Goldman S, Wong MC et al (1996) Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children\u2019s Cancer Group. J Clin Oncol 14(9):2495\u20132503","journal-title":"J Clin Oncol"},{"issue":"3","key":"3003_CR44","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF02341155","volume":"9","author":"JL Finlay","year":"1990","unstructured":"Finlay JL, August C, Packer R et al (1990) High-dose multi-agent chemotherapy followed by bone marrow \u2018rescue\u2019 for malignant astrocytomas of childhood and adolescence. J Neurooncol 9(3):239\u2013248","journal-title":"J Neurooncol"},{"issue":"1","key":"3003_CR45","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0959-8049(96)00369-3","volume":"33","author":"E Bouffet","year":"1997","unstructured":"Bouffet E, Mottolese C, Jouvet A et al (1997) Etoposide and thiotepa followed by ABMT (autologous bone marrow transplantation) in children and young adults with high-grade gliomas. Eur J Cancer 33(1):91\u201395","journal-title":"Eur J Cancer"},{"issue":"10","key":"3003_CR46","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1002\/cncr.20227","volume":"100","author":"F Fagioli","year":"2004","unstructured":"Fagioli F, Biasin E, Mastrodicasa L et al (2004) High-dose thiotepa and etoposide in children with poor-prognosis brain tumors. Cancer 100(10):2215\u20132221","journal-title":"Cancer"},{"issue":"7","key":"3003_CR47","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1200\/JCO.1998.16.7.2486","volume":"16","author":"S Guruangan","year":"1998","unstructured":"Guruangan S, Dunkel IJ, Goldman S et al (1998) Myeloablative chemotherapy with autologous bone marrow rescue in young children with recurrent malignant brain tumors. J Clin Oncol 16(7):2486\u20132493","journal-title":"J Clin Oncol"},{"issue":"5","key":"3003_CR48","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/mpo.2950230507","volume":"23","author":"A Kedar","year":"1994","unstructured":"Kedar A, Maria BL, Graham-Pole J et al (1994) High-dose chemotherapy with marrow reinfusion and hyperfractionated irradiation for children with high-risk brain tumors. Med Pediatr Oncol 23(5):428\u2013436","journal-title":"Med Pediatr Oncol"},{"issue":"1","key":"3003_CR49","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1023\/A:1005874508975","volume":"37","author":"IJ Dunkel","year":"1998","unstructured":"Dunkel IJ, Garvin JH Jr, Goldman S et al (1998) High dose chemotherapy with autologous bone marrow rescue for children with diffuse pontine brain stem tumors. Children\u2019s Cancer Group. J Neurooncol 37(1):67\u201373","journal-title":"J Neurooncol"},{"issue":"3","key":"3003_CR50","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<685::AID-CNCR27>3.0.CO;2-K","volume":"88","author":"E Bouffet","year":"2000","unstructured":"Bouffet E, Raquin M, Doz F et al (2000) Radiotherapy followed by high dose busulfan and thiotepa: a prospective assessment of high dose chemotherapy in children with diffuse pontine gliomas. Cancer 88(3):685\u2013692","journal-title":"Cancer"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-018-03003-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-018-03003-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-018-03003-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T20:23:05Z","timestamp":1572726185000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-018-03003-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,3]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3003"],"URL":"https:\/\/doi.org\/10.1007\/s11060-018-03003-z","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,3]]},"assertion":[{"value":"14 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Ira J. Dunkel: Consultant, current: Apexigen (May 26, 2017 to present), Bayer HealthCare Pharmaceuticals (March 30, 2016\u2013March 30, 2020), Celgene (May 2, 2017\u2013March 31, 2020). The Celgene agreement is actually not finalized, but has a pending start date of May 2, 2017 despite that being in the past. Consultant, past: Bayer HealthCare Pharmaceuticals (October 1, 2011\u2013October 1, 2012), Bristol-Myers Squibb (June 11, 2012\u2013June 11, 2013; April 24, 2015\u2013April 24, 2017), Ipsen (August 20, 2014\u2013August 20, 2015), Eisai (October 1, 2015\u2013October 1, 2016). Pfizer (January 20, 2016\u2013January 20, 2017). All other authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}